Table 4 Lung cancer member characteristics by stage, diagnosed 2016–2020 (N = 3,459)

n (%)^{a, b}

793 (22.9%)

483 (14.0%)

711 (20.6%)

1,472 (42.6%)

Age, mean (SD), years^b

68.6 (9.9)

66.9 (10.1)

66.7 (9.9)

65.1 (10.6)

Female Gender, n (%)^b

472 (59.5%)

246 (50.9%)

355 (49.9%)

746 (50.7%)

Insurance Type, n (%)^{a, b}

 Commercial

213 (26.9%)

148 (30.6%)

202 (28.4%)

593 (40.3%)

 Medicaid

34 (4.3%)

27 (5.6%)

51 (7.2%)

71 (4.8%)

 Medicare Advantage

514 (64.8%)

285 (59.0%)

420 (59.1%)

721 (49.0%)

 Multiple^c

1 (0.1%)

0 (0.0%)

1 (0.1%)

5 (0.3%)

 Unknown

31 (3.9%)

23 (4.8%)

37 (5.2%)

82 (5.6%)

Geographic Region, n (%)^{a, b}

 Midwest

321 (40.5%)

203 (42.0%)

336 (47.3%)

575 (39.1%)

 Northeast

301 (38.0%)

155 (32.1%)

200 (28.1%)

478 (32.5%)

 South

101 (12.7%)

72 (14.9%)

114 (16.0%)

243 (16.5%)

 West

46 (5.8%)

30 (6.2%)

45 (6.3%)

137 (9.3%)

 Unknown

24 (3.0%)

23 (4.8%)

16 (2.3%)

39 (2.7%)

CCI, mean (SD)^d

2.2 (1.9)

2.0 (1.9)

2.0 (1.8)

1.8 (1.8)

CCI, n (%)^{a, d}

 0

66 (16.5%)

58 (21.1%)

73 (17.8%)

219 (24.1%)

 1

116 (28.9%)

92 (33.5%)

128 (31.2%)

275 (30.3%)

 2

80 (20.0%)

41 (14.9%)

79 (19.3%)

173 (19.1%)

  ≥ 3

139 (34.7%)

84 (30.5%)

130 (31.7%)

240 (26.5%)